All In MedTech

FDA Clearance Tracker · P100020-S025

cobas HPV Test, 240 Tests

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 2, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P100020-S025
Device name
cobas HPV Test, 240 Tests
Applicant location
Pleasanton, CA
Received
Jul 28, 2017
Decided
Jul 2, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100020

Device type

Device class
Class III

Every decision under product code MAQ

FDA's approval statement

As written in FDA's record.

Approval for an expansion of the intended use for the FDA-approved cobas HPV Test to include cervical specimens collected in SurePath Preservative Fluid as a specimen type

Source documents

Other decisions for Roche Molecular Systems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.